HPV & Screening
RISCC stands for “RIsk-based Screening for Cervical Cancer” and has received funding from the European Union’s Horizon2020 Framework Programme for Research and Innovation.
Screening in the Nonavalent Vaccine Era: What Do We Know and What Do We Need to Know?
World expert, Joakim Dillner, Karolinska Institute and Karolinska Hospital, Sweden shares the latest insights and take-home messages on HPV and Screening at the ENGAGe Patient Seminar in Antalya, during the ESGO 2016 State of the Art Conference.
Watch the video on the ENGAGe Channel!